1. Introduction
===============

Transmetalation between organoboronic reagents and transition metals is a fundamental process involved in many metal-catalyzed C-C bond-forming reactions \[[@B1-molecules-16-05020],[@B2-molecules-16-05020]\]. In this field, we reported a new catalytic cycle starting from transmetalation to give an organorhodium(I), -palladium(II) or -ruthenium(II) intermediate for 1,4-addition of organoboronic acids to electron-deficient alkenes and arylation of the carbon-heteroatom double bond of aldehydes and N-sulfonylimines \[[@B3-molecules-16-05020],[@B4-molecules-16-05020],[@B5-molecules-16-05020]\]. We have developed new bidentate chiral phosphoramidites \[Me-BIPAM (**6**), N-Me-BIPAM (**7**)\] based on linked-BINOL for enantioselective 1,4-addition of arylboronic acids to enones \[[@B6-molecules-16-05020],[@B7-molecules-16-05020]\], arylation of aldimines \[[@B8-molecules-16-05020]\] and hydrogenation of α-dehydroamino esters \[[@B9-molecules-16-05020]\] with rhodium catalysts. These ligands were also found to be highly efficient for ruthenium-catalyzed enantioselective arylation of aromatic aldehydes \[[@B10-molecules-16-05020]\]. Herein, we report arylation of aliphatic aldehydes **1** and α-ketoesters **2** with arylboronic acids **3** catalyzed by a chiral ruthenium complex, generated *in situ* from \[RuCl~2~(*p*-cymene)\]~2~ and (*R,R*)-Me-BIPAM (**6**) ([Scheme 1](#molecules-16-05020-scheme1){ref-type="scheme"}).

![Arylation of aliphatic aldehydes and α-ketoesters.](molecules-16-05020-g001){#molecules-16-05020-scheme1}

2. Results and Discussion
=========================

The arylation of carbonyl compounds with organolithium \[[@B11-molecules-16-05020],[@B12-molecules-16-05020]\], organomagnesium \[[@B13-molecules-16-05020],[@B14-molecules-16-05020],[@B15-molecules-16-05020]\] and organozinc \[[@B16-molecules-16-05020],[@B17-molecules-16-05020],[@B18-molecules-16-05020],[@B19-molecules-16-05020],[@B20-molecules-16-05020],[@B21-molecules-16-05020]\] reagents are the traditional ways to access alkyl(aryl)methanol and α-hydroxy-esters, but there has been recent interest in the transition-metal-catalyzed arylation using tin \[[@B22-molecules-16-05020]\] and boron \[[@B23-molecules-16-05020],[@B24-molecules-16-05020],[@B25-molecules-16-05020],[@B26-molecules-16-05020],[@B27-molecules-16-05020]\] compounds. Since the corresponding rhodium complexes were inefficient, we previously developed a highly enantioselective arylation of aldehydes with boronic acids by using ruthenium catalyst \[[@B10-molecules-16-05020]\]. In our continuing program to expand the utility of the ruthenium/Me-bipam catalyst, we planned to develop an enantioselective addition of arylboronic acids to aliphatic aldehydes. \[RuCl~2~(*p*-cymene)\]/Me-bipam (2 mol%) catalyzed the addition of arylboronic acids to representative aliphatic aldehydes in high yields in the presence of one equivalent of K~2~CO~3~ at 60 °C in toluene/H~2~O (10:1). A variety of aliphatic aldehydes underwent the arylation reaction ([Table 1](#molecules-16-05020-t001){ref-type="table"}). Not only linear aliphatic aldehydes but also branched ones participated in the arylation reaction. Most reactions took place smoothly in toluene/H~2~O (10/1), but toluene/H~2~O (5/1) was a better solvent for the slow addition ([Table 1](#molecules-16-05020-t001){ref-type="table"}, entries 1, 6, 10, 11, 17-19).

Next, we employed Ru/Me-BIPAM as the catalyst for the addition reaction of arylboronic acids to α-ketoesters, could yield useful α-hydroxy-esters with α-quaternary carbon centers. The rhodium(I)/(*S*)-Ship complex developed by Zhou and co-workers was the most promising catalyst, achieving 80-93% ee for 2-oxo-2-arylacetate and 2-oxo-4-phenyl-3-butenoate \[[@B29-molecules-16-05020]\]. Several bases were screened for the reactions involving a \[RuCl~2~(*p*-cymene)\]~2~/2Me-bipam catalyst ([Table 2](#molecules-16-05020-t002){ref-type="table"}).

molecules-16-05020-t001_Table 1

###### 

Arylation of aliphatic aldehydes *^a^*.

![](molecules-16-05020-i001.jpg)

  Entry          R^1^ =                       Ar =                               Yield (%)      ee (%) (abs)
  -------------- ---------------------------- ---------------------------------- -------------- --------------
  1 *^b^*        *n*-C~2~H~5~ (**1a**)        Ph (**3a**)                        63 (**4aa**)   91 (*R*)
  2              *n*-C~4~H~9~ (**1b**)        Ph (**3a**)                        93 (**4ba**)   94 (*R*)
  3              *n*-C~4~H~9~ (**1b**)        2-naphthyl (**3b**)                98 (**4bb**)   93 (*R*)
  4              *n*-C~4~H~9~ (**1b**)        4-MeC~6~H~4~ (**3c**)              85 (**4bc**)   92 (*R*)
  5              *n*-C~4~H~9~ (**1b**)        4-MeOC~6~H~4~ (**3d**)             93 (**4bd**)   92 (*R*)
  6 *^b,c^*      *n*-C~4~H~9~ (**1b**)        4-ClC~6~H~4~ (**3e**)              90 (**4be**)   87 (*R*)
  7              *n*-C~4~H~9~ (**1b**)        4-FC~6~H~4~ (**3f**)               69 (**4bf**)   91 (*R*)
  8              *n*-C~4~H~9~ (**1b**)        3-MeOC~6~H~4~ (**3h**)             62 (**4bh**)   90 (*R*)
  9              *n*-C~4~H~9~ (**1b**)        3-ClC~6~H~4~ (**3i**)              63 (**4bi**)   90 (+)
  10 *^b,d^*     *n*-C~4~H~9~ (**1b**)        3-F-4-MeOC~6~H~3~ (**3k**)         65 (**4bk**)   87 (+)
  11 *^b,c^*     *n*-C~4~H~9~ (**1b**)        3,4-(CH~2~O~2~)C~6~H~3~ (**3l**)   58 (**4bl**)   99 (*R*)
  12             *n*-C~5~H~11~ (**1c**)       Ph (**3a**)                        91 (**4ca**)   94 (*R*)
  13             *n*-C~6~H~13~ (**1d**)       Ph (**3a**)                        93 (**4da**)   93 (*R*)
  14 *^c^*       *n*-C~8~H~17~ (**1e**)       Ph (**3a**)                        87 (**4ea**)   92 (*R*)
  15             PhCH~2~CH~2~ (**1f**)        Ph (**3a**)                        99 (**4fa**)   92 (*R*)
  16             *cyclo*-C~6~H~11~ (**1g**)   Ph (**3a**)                        78 (**4ga**)   94 (*R*)
  17 *^b^*       *i*-Pr (**1h**)              Ph (**3a**)                        67 (**4ha**)   96 (*R*)
  18 *^b,c^*     (C~2~H~5~)~2~CH (**1j**)     Ph (**3a**)                        54 (**4ja**)   91 (*R*)
  19 *^b,c,e^*   *t*-Bu (**1k**)              Ph (**3a**)                        40 (**4ka**)   99 (*R*)

*^a^* Reaction conditions: A mixture of aldehyde (0.5 mmol), ArB(OH)~2~ (0.75 mmol), K~2~CO~3~ (0.5 mmol), \[RuCl~2~(*p*-cymen)\]~2~ (1 mol%) and (*R,R*)-Me-BIPAM (2.2 mol%) in toluene (3 mL) and H~2~O (0.3 mL) was stirred at 60 °C for 16 h. *^b^* toluene/H~2~O (5/1) was used. *^c^* at 80 °C. *^d^* KOH was used. *^e^* K~3~PO~4~ was used.

molecules-16-05020-t002_Table 2

###### 

Reaction conditions *^a^*.

![](molecules-16-05020-i002.jpg)

  Entry     Base        R^3^ =            Yield (%)   ee (%) (abs)
  --------- ----------- ----------------- ----------- --------------
  1 *^b^*   K~2~CO~3~   Et                40          93
  2 *^b^*   K~3~PO~4~   Et                trace       ND
  3 *^b^*   CsF         Et                40          93
  4 *^b^*   KF          Et                71          95
  5         KF          Et                78          94
  **6**     **KF**      ***i*-Pr (2a)**   **85**      **93 (*S*)**
  7         KF          *t*-Bu            87          90
  8 *^c^*   KF          *t*-Bu            72          70

*^a^* Reaction conditions: A mixture of alkyl pyruvate (0.5 mmol), PhB(OH)~2~ (1.0 mmol), base (1.0 mmol), \[RuCl~2~(*p*-cymen)\]~2~ (1 mol%) and (*R,R*)-Me-BIPAM (2.2 mol%) in toluene (3 mL) and H~2~O (0.3 mL) was stirred at 80 °C for 16 h. *^b^* at 50 °C. *^c^* (*R,R*)-N-Me-BIPAM was used.

K~2~CO~3~, K~3~PO~4~ or CsF resulted in lower yields ([Table 2](#molecules-16-05020-t002){ref-type="table"}, entries 1-3). The highest efficiency with regard to the reaction was observed when KF was used for the arylation of isopropyl pyruvate with phenylboronic acid at 80 °C ([Table 2](#molecules-16-05020-t002){ref-type="table"}, entry 6). The yield of the product was dependent on the bulkiness of the ester moiety of the substrate ([Table 2](#molecules-16-05020-t002){ref-type="table"}, entries 5-7), and the best results were obtained with isopropyl ester as the substrate. Among chiral ligands screened, *N*-Me-bipam (**7**) achieved a 70% ee (entry 8). Substrate generality was then investigated under the optimized reaction conditions ([Table 3](#molecules-16-05020-t003){ref-type="table"}). High ee values were obtained with methyl, ethyl, and phenyl-substituted ketoesters. Representative *meta*- and *para*-substituted arylboronic acids with electron-donating or electron-withdrawing substituents afforded good yields of tertiary α-hydroxy-esters with high enantioselectivities. (*R,R*)-Me-bipam has given the products **4** and **5** by the same enantioselection. To elucidate the enantioselection in the mechanism, the characterization of the catalyst and the intermediate are in progress.

molecules-16-05020-t003_Table 3

###### 

Arylation of α-ketoesters *^a^*.
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  Entry   R^2^ =                 Ar =                         Yield (%)      ee (%) (abs)
  ------- ---------------------- ---------------------------- -------------- --------------
  1       Me (**2a**)            Ph (**3a**)                  85 (**5aa**)   93 (*S*)
  2       Me (**2a**)            4-MeC~6~H~4~ (**3c**)        84 (**5ac**)   89
  3       Me (**2a**)            4-MeOC~6~H~4~ (**3d**)       84 (**5ad**)   91
  4       Me (**2a**)            4-FC~6~H~4~ (**3f**)         85 (**5af**)   93
  5       Me (**2a**)            4-CF~3~C~6~H~4~ (**3g**)     64 (**5ag**)   92
  6       Me (**2a**)            3-MeOC~6~H~4~ (**3h**)       73 (**5ah**)   92
  7       Me (**2a**)            3-FC~6~H~4~ (**3j**)         71 (**5aj**)   90
  8       Me (**2a**)            3-F-4-MeOC~6~H~3~ (**3k**)   81 (**5ak**)   87
  9       Et (**2b**)            Ph (**3a**)                  88 (**5ba**)   95
  10      Et (**2b**)            4-MeC~6~H~4~ (**3c**)        90 (**5bc**)   91
  11      Et (**2b**)            4-FC~6~H~4~ (**3f**)         90 (**5bf**)   93
  12      Et (**2b**)            3-MeOC~6~H~4~ (**3h**)       88 (**5bh**)   91
  13      *i-*Pr (**2c**)        Ph (**3a**)                  41 (**5ca**)   94
  14      *i-*Pr (**2c**)        4-MeOC~6~H~4~ (**3d**)       42 (**5cd**)   90
  15      Ph (**2d**)            4-MeC~6~H~4~ (**3c**)        82 (**5dc**)   92
  16      Ph (**2d**)            4-MeOC~6~H~4~ (**3d**)       95 (**5dd**)   86
  17      Ph (**2d**)            4-ClC~6~H~4~ (**3e**)        90 (**5de**)   91
  18      Ph (**2d**)            4-FC~6~H~4~ (**3f**)         90 (**5df**)   94
  19      Ph (**2d**)            3-MeOC~6~H~4~ (**3h**)       79 (**5dh**)   92
  20      4-FC~6~H~4~ (**2e**)   3-ClC~6~H~4~ (**3i**)        67 (**5ei**)   90

^a^ Reaction conditions: A mixture of α-ketoester (0.5 mmol), ArB(OH)~2~ (1.0 mmol), KF (1.0 mmol), \[RuCl~2~(*p*-cymen)\]~2~ (1 mol%) and (*R,R*)-Me-BIPAM (2.2 mol%) in toluene (3 mL) and H~2~O (0.3 mL) was stirred at 80 °C for 16 h.

3. Experimental Section
=======================

3.1. General
------------

^1^H--NMR spectra were recorded on a JEOL ECX-400 (400 MHz) in CDCl~3~ with tetramethylsilane as an internal standard. Chemical shifts are reported in part per million (ppm), and signal are expressed as singlet (s), doublet (d), triplet (t), quartet (q), multiplet (m), and broad (br). ^13^C-NMR spectra were recorded on a JEOL ECX-400 (100 MHz) in CDCl~3~ (δ~C~ = 77.0) with tetramethylsilane as an internal standard. Chemical shifts are reported in part per million (ppm). HPLC analysis was directly performed with chiral stationary phase column, Chiralpak AD-H, IB or Chiralcel OD-H, OB-H purchased from DAICEL Co., Ltd. High resolution mass spectra (HRMS) were recorded on a JEOL JMS 700TZ mass spectrometer at the Center *for Instrumental Analysis*, Hokkaido University. Optical rotations were measured on a HORIBA SEPA-300 digital polarimeter. Kanto Chemical silica gel 60N (particle size 0.063-0.210 mm) was used for flash column chromatography. RuCl~3~·xH~2~O were purchesed from Strem Chemical, Inc. \[RuCl~2~(p-cymene)\]~2~ \[[@B28-molecules-16-05020]\], BIPAM ligands (Me-BIPAM, N-Me-BIPAM) were prepared according to our previous procedure \[[@B7-molecules-16-05020],[@B8-molecules-16-05020]\]. Me-BIPAM was commercially available from Wako Pure Chemical Industries, Ltd.

3.2. General Procedure for Arylation of Aliphatic Aldehydes ([Table 1](#molecules-16-05020-t001){ref-type="table"})
-------------------------------------------------------------------------------------------------------------------

A flask was charged with \[RuCl~2~(*p*-cymene)\]~2~ (0.005 mmol, 1 mol%) and (*R,R*)-Me-bipam (0.011 mmol, 2.2 mol%) under a nitrogen atmosphere. Toluene (3.0 mL) was added to the flask and the mixture was then stirred at room temperature for 30 min to prepare the catalyst. Pentanal (**1b**, 0.5 mmol), phenylboronic acid (**3a**, 0.75 mmol), K~2~CO~3~ (0.5 mmol), and H~2~O (0.3 mL) were then added to this catalyst solution. The reaction mixture was stirred at 60 °C for 16 h, at which time the crude reaction mixture extracted using ethyl acetate, washed with saturated NH~4~Cl and brine, and dried over MgSO~4~. Chromatography of the crude reaction mixture on silica gel gave *(R)-1-phenyl-1-pentanol* (**4ba**) \[[@B29-molecules-16-05020]\] in 93% yield; \[α\]~D~^23^ = 33.8 (c 0.80, C~6~H~6~), 94% ee \[HPLC conditions: Chiralcel OD, hexane/2-propanol = 99/1, flow = 0.85 mL min^−1^, wavelength = 254 nm, t~major~ = 22.7 and t~minor~ = 26.6 min\]; ^1^H-NMR (400 MHz, CDCl~3~): δ = 7.34-7.25 (m, 5H), 4.65 (t, *J* = 6.8 Hz, 1H), 1.86-1.70 (m, 3H), 1.39-1.25 (m, 4H), 0.88 (t, *J* = 7.0 Hz, 3H); HRMS *m/z*; calcd. For C~11~H~16~O: 164.1201; found 164.1203.

*(R)-1-Phenyl-1-propanol* (**4aa**) \[[@B29-molecules-16-05020],[@B30-molecules-16-05020]\]: \[α\]~D~^21^ = 43.4 (c 0.87, CHCl~3~) 91% ee \[HPLC conditions: Chiralpak OD, hexane/2-propanol = 99/1, flow = 0.8 mL min^−1^, wavelength = 254 nm, t~major~ = 26.0 and t~minor~ = 33.0 min\]; ^1^H-NMR (400 MHz, CDCl~3~): δ = 7.34-7.25 (m, 5H), 4.60 (t, *J* = 6.6 Hz, 1H), 1.88-1.71 (m, 3H), 0.91 (t, *J* = 7.5 Hz, 3H); HRMS *m/z*; calcd. for C~9~H~12~O: 136.08881; found 136.08881.

*(R)-1-(-2-Naphthyl)-1-pentanol* (**4bb**) \[[@B31-molecules-16-05020]\]: \[α\]~D~^19^ = 33.8 (c 1.52, CHCl~3~), 93% ee \[HPLC conditions: Chiralcel OD, hexane/2-propanol = 50/1, flow = 1.0 mL min^−1^, wavelength = 254 nm, t~minor~ = 27.0 and t~major~ = 29.6 min\]; ^1^H-NMR (400 MHz, CDCl~3~): δ = 7.87-7.77 (m, 4H), 7.51-7.45 (m, 3H), 4.85 (t, *J* = 6.6 Hz, 1H), 1.94-1.79 (m, 3H), 1.46-1.26 (m, 4H), 0.89 (t, *J* = 7.0 Hz, 3H).

*(R)-1-(4-Tolyl)-1-pentanol* (**4bc**) \[[@B29-molecules-16-05020],[@B32-molecules-16-05020]\]: \[α\]~D~^22^ = 29.4 (c 0.80, C~6~H~6~), 92% ee \[HPLC conditions: Chiralcel OJ, hexane/2-propanol = 200/1, flow = 1.0 mL min^−1^, wavelength = 254 nm, t~major~ = 20.4 and t~minor~ = 22.6 min\]; ^1^H-NMR (400 MHz, CDCl~3~): δ = 7.26-7.15 (m, 4H), 4.63 (t, *J* = 6.2 Hz, 1H), 2.34 (s, 3H), 1.85-1.64 (m, 3H), 1.42-1.20 (m, 4H), 0.88 (t, *J* = 7.0 Hz, 3H).

*(R)-1-(4-Methoxyphenyl)-1-pentanol* (**4bd**) \[[@B33-molecules-16-05020]\]: \[α\]~D~^19^ = 26.9 (c 0.37, CHCl~3~), 92% ee \[HPLC conditions: Chiralcel OD, hexane/2-propanol = 99/1, flow = 0.8 mL min^−1^, wavelength = 254 nm, t~major~ = 37.4 and t~minor~ = 41.0 min\]; ^1^H-NMR (400 MHz, CDCl~3~): δ = 7.27 (d, *J* = 8.0 Hz,2H ), 6.89 (d, *J* = 8.8 Hz,2H), 4.61 (t, *J* = 6.8 Hz, 1H), 3.81 (s, 3H), 1.85-1.64 (m, 2H), 1.41-1.20 (m, 4H), 0.88 (t, *J* = 7.4 Hz, 3H); HRMS *m/z*; calcd. for C~12~H~18~O~2~: 194.13068; found 194.13084.

*(R)-1-(4-Chlorophenyl)-1-pentanol* (**4be**) \[[@B29-molecules-16-05020]\]: \[α\]~D~^22^ = 18.3 (c 0.60, C~6~H~6~), 87% ee \[HPLC conditions: Chiralcel OD, hexane/2-propanol = 99/1, flow = 0.8 mL min^−1^, wavelength = 230 nm, t~minor~ = 24.5 and t~major~ = 27.0 min\]; ^1^H-NMR (400 MHz, CDCl~3~): δ = 7.34-7.29 (m, 4H), 4.66 (t, *J* = 7.2 Hz, 1H), 1.82-1.56 (m, 3H), 1.40-1.26 (m, 4H), 0.88 (t, *J* = 6.2 Hz, 3H); HRMS *m/z*; calcd. for C~11~H~15~C1O: 198.08114; found 198.08132.

*(R)-1-(4-Fluorophenyl)-1-pentanol* (**4bf**) \[[@B34-molecules-16-05020]\]: \[α\]~D~^21^ = 40.5 (c 0.50, CHCl~3~), 91% ee \[HPLC conditions: Chiralpak AD-H, hexane/2-propanol = 99/1, flow = 0.8 mL min^−1^, wavelength = 230 nm, t~minor~= 27.3 and t~major~ = 31.5 min\]; ^1^H-NMR (400 MHz, CDCl~3~): δ = 7.34-7.26 (m, 3H), 7.06-7.00 (t, *J* = 8.5 Hz, 2H), 4.66 (t, *J* = 6.2 Hz, 1H), 1.78-1.61 (m, 3H), 1.35-1.26 (m, 4H), 0.87 (t, *J* = 6.2 Hz, 3H); ^13^C-NMR (100 MHz, CDCl~3~): δ = 162.2 (d, *J* = 245 Hz), 140.7 (d, *J* = 2.86 Hz), 127.6 (d, *J* = 7.63 Hz), 115.3 (d, *J* = 20.98 Hz), 74.1, 39.0, 28.0, 22.7, 14.1; HRMS *m/z*; calcd. for C~11~H~15~FO: 182.11069; found 182.11040.

*(R)-1-(3-Methoxyphenyl)-1-pentanol* (**4bh**) \[[@B35-molecules-16-05020]\]: \[α\]~D~^20^ = 30.2 (c 0.90, THF), 90% ee \[HPLC conditions: Chiralcel OD, hexane/2-propanol = 99/1, flow = 0.7 mL min^−1^, wavelength = 254 nm, t~major~ = 58.3 and t~minor~ = 67.9 min\]; ^1^H-NMR (400 MHz, CDCl~3~): δ= 7.26 (s, 1H), 7.14-7.02 (m, 2H), 6.92 (t, *J* = 8.4 Hz, 1H), 4.64 (t, *J* = 6.6 Hz, 1H), 3.81 (s, 3H), 1.83-1.63 (m, 3H), 1.39-1.19 (m, 4H), 0.88 (t, *J* = 7.0 Hz, 3H); HRMS m/z; calcd. for C~12~H~18~O~2~: 194.13068; found 194.13040.

*1-(3-Chlorophenyl)-1-pentanol* (**4bi**) \[[@B32-molecules-16-05020]\]: \[α\]~D~^20^ = 24.0 (c 0.39, CHCl~3~), 90% ee \[HPLC conditions: Chiralcel OD, hexane/2-propanol = 99/1, flow = 0.8 mL min^−1^, wavelength = 230 nm, t~minor~ = 23.1 and t~major~ = 25.4 min\]; ^1^H-NMR (400 MHz, CDCl~3~): δ = 7.40-7.18 (m, 4H), 4.64 (t, *J* = 6.6 Hz, 1H), 1.83-1.61 (m, 2H), 1.41-1.20 (m, 4H), 0.88 (t, *J* = 7.0 Hz, 3H); HRMS *m/z*; calcd. for C~11~H~15~ClO: 198.08114; found 198.08097.

*1-(3-Fluoro-4-methoxyphenyl)-1-pentanol* (**4bk**): \[α\]~D~^20^ = 23.6 (c 0.33, CHCl~3~), 87% ee \[HPLC conditions: Chiralcel OD, hexane/2-propanol = 99/1, flow = 0.75 mL min^−1^, wavelength = 230 nm, t~major~ = 37.0 and t~minor~ = 40.7 min\]; ^1^H-NMR (400 MHz, CDCl~3~): δ = 6.94-6.89 (m, 2H), 6.84-6.79 (m, 1H), 4.65 (t, *J* = 6.6 Hz, 1H), 3.82 (s, 3H), 1.84-1.64 (m, 3H), 1.42-1.22 (m, 4H), 0.89 (t,*J* = 7.4 Hz, 3H); ^13^C-NMR (100 MHz, CDCl~3~): δ = 152.4 (d, *J* = 246 Hz), 146.9 (d, *J* = 10.49 Hz), 138.2 (d, *J* = 4.77 Hz), 121.7 (d, *J* = 3.81 Hz), 113.8 (d, *J* = 18.12 Hz), 113.2, 73.9, 56.4, 38.8, 28.0, 22.7, 14.1; HRMS *m/z*; calcd. for C~12~H~17~FO~2~: 212.12126; found 212.12104.

*(R)-1-(5-Benzo\[d\]\[1,3\]dioxolyl)-1-pentanol* (**4bl**) \[[@B36-molecules-16-05020]\]: \[α\]~D~^20^ = 62.4 (c 0.48, CHCl~3~), 99% ee \[HPLC conditions: Chiralcel OD, hexane/2-propanol = 99/1, flow = 0.8 mL min^−1^, wavelength = 254 nm, t~minor~= 39.9 (S) and t~major~ = 44.8 min\]; ^1^H-NMR (400 MHz, CDCl~3~): δ = 6.87 (s, 1H), 6.78 (s, 2H), 5.95 (s, 2H), 4.58 (t, *J* = 7.2 Hz, 1H), 1.83-1.59 (m, 3H), 1,40-1.18 (m, 4H), 0.88 (t, *J* = 7.0 Hz, 3H).

*(R)-1-Phenyl-1-hexanol* (**4ca**) \[[@B37-molecules-16-05020]\]: \[α\]~D~^23^ = 37.5 (c 0.82, CHCl~3~), 94% ee \[HPLC conditions: Chiralcel OD, hexane/2-propanol = 99/1, flow = 0.9 mL min^−1^, wavelength = 254 nm, t~major~ = 19.2 and t~minor~ = 22.4 (S) min\]; ^1^H-NMR (400 MHz, CDCl~3~): δ = 7.34-7.25 (m, 5H), 4.66 (t, *J* = 6.8 Hz, 1H), 1.87-1.61 (m, 3H), 1.42-1.22 (m, 6H), 0.88 (t, *J* = 7.0 Hz, 3H); HRMS *m/z*; calcd. for C~12~H~18~O: 178.1358; found 178.1353.

*(R)-1-Phenyl-1-heptanol* (**4da**) \[[@B38-molecules-16-05020],[@B39-molecules-16-05020]\]: \[α\]~D~^23^ = 31.2 (c 0.85, CHCl~3~ ), 93% ee \[HPLC conditions: Chiralcel OD, hexane/2-propanol = 99/1, flow = 0.9 mL min^−1^, wavelength = 254 nm, t~major~ = 19.9 and t~minor~ = 22.9 min\]; ^1^H-NMR (400 MHz, CDCl~3~): δ = 7.34-7.25 (m, 6H), 4.66 (t, *J* = 6.6 Hz, 1H), 1.84-1.56 (m, 2H), 1.40-1.25 (m, 8H), 1.42-1.23 (m, 12H), 0.86 (t, *J* = 6.6 Hz, 3H); HRMS *m/z*; calcd. for C~13~H~20~O: 192.1514; found 192.1511.

*(R)-1-Phenyl-1-nonanol* (**4ea**) \[[@B40-molecules-16-05020],[@B41-molecules-16-05020]\]: \[α\]~D~^19^ = 27.3 (c 1.42, CHCl~3~ ), 92% ee \[HPLC conditions: Chiralcel OD, hexane/2-propanol = 99/1, flow = 0.7 mL min^−1^, wavelength = 254 nm, t~major~ = 25.0 and t~minor~ = 31.8 min\]; ^1^H-NMR (400 MHz, CDCl~3~): δ = 7.34-7.25 (m, 5H), 4.66 (t, *J* = 6.1 Hz, 1H), 1.93-1.65 (m, 3H), 1.42-1.19 (m, 12H), 0.87 (t, *J* = 6.6 Hz, 3H); HRMS *m/z*; calcd. for C~15~H~24~O: 220.1827; found 220.1822.

*(R)-1,3-Diphenyl-1-propanol* (**4fa**) \[[@B42-molecules-16-05020]\]: \[α\]~D~^20^ = 15.6 (c 0.85, CH~2~Cl~2~), 92% ee \[HPLC conditions: Chiralcel OD, hexane/2-propanol = 95/5, flow = 0.7 mL min^−1^, wavelength = 254 nm, t~minor~ = 28.2 and t~major~ = 33.7 min\]; ^1^H-NMR (400 MHz, CDCl~3~): δ = 7.38-7.14 (m, 10H), 4.68 (t, *J* = 6.6 Hz, 1H), 2.77-2.65 (m, 2H), 2.15-2.02 (m, 2H), 1.92 (s, 1H); HRMS *m/z*; calcd. for C~15~H~16~O: 212.1201; found 212.1197.

*(R)-Cyclohexyl(phenyl)methanol* (**4ga**) \[[@B33-molecules-16-05020]\]: \[α\]~D~^20^ = 39.5 (c 0.23, CHCl~3~), 94% ee \[HPLC conditions: Chiralcel OD, hexane/2-propanol = 99/1, flow = 0.4 mL min^−1^, wavelength = 254 nm, t~minor~ = 45.2 and t~major~ = 48.8 min\]; ^1^H-NMR (400 MHz, CDCl~3~): δ = 7.35-7.24 (m, 5H), 4.35 (d, *J* = 7.3 Hz, 1H), 2.03-1.60 (m, 6H), 1.38-0.90 (m, 6H); HRMS *m/z*; calcd. for C~13~H~18~O: 190.1358; found 190.1358.

*(R)-2-Methyl-1-phenyl-1-propanol* (**4ha**) \[[@B33-molecules-16-05020]\]: \[α\]~D~^19^ = 11.3 (c 0.42, CHCl~3~), 96% ee \[HPLC conditions: Chiralpak AD-H, hexane/2-propanol = 99/1, flow = 1.0 mL min^−1^, wavelength = 254 nm, t~major~ = 17.6 and t~minor~ = 18.8 min\]; ^1^H-NMR (400 MHz, CDCl~3~): δ = 7.35-7.28 (m, 5H), 4.35 (d, *J* = 6.8 Hz, 1H), 2.00-1.89 (m, 1H), 1.82 (broad s, 1H), 1.00 (d, *J* = 6.8 Hz, 3H), 0.79 (d,*J* = 6.8 Hz, 3H); HRMS *m/z*; calcd. for C~10~H~14~O: 150.1045; found 150.1043.

*(R)-2-Ethyl-1-phenyl-1-butanol* (**4ja**) \[[@B43-molecules-16-05020]\]: \[α\]~D~^20^ = −10.6 (c 0.35, CHCl~3~), 91% ee \[HPLC conditions: Chiralcel OD, hexane/2-propanol = 99/1, flow = 0.5 mL min^−1^, wavelength = 254 nm, t~major~ = 29.2 and t~minor~ = 44.5 min\]; ^1^H-NMR (400 MHz, CDCl~3~): δ = 7.36-7.24 (m, 5H), 4.63 (d, *J* = 6.3 Hz, 1H), 1.77 (broad s, 1H), 1.60-1.40 (m, 2H), 0.90-0.82 (m, 6H); HRMS *m/z*; calcd. for C~12~H~18~O: 178.1358; found 178.1354.

*(R)-2,2-Dimethyl-1-phenyl-1-propanol* (**4ka**) \[[@B33-molecules-16-05020]\]: \[α\]~D~^20^ = 19.2 (c 0.48, CHCl~3~), 99% ee \[HPLC conditions: Chiralpak OD, hexane/2-propanol = 98/2, flow = 0.9 mL min^−1^, wavelength = 254 nm, t~minor~ = 7.9 and t~major~ = 11.7 min\]; ^1^H-NMR (400 MHz, CDCl~3~): δ = 7.32-7.26 (m, 5H), 4.40 (s, 1H), 0.93 (s, 9H).

3.3. General Procedure for Arylation of α-Ketoesters ([Table 3](#molecules-16-05020-t003){ref-type="table"})
------------------------------------------------------------------------------------------------------------

A flask was charged with \[RuCl~2~(*p*-cymene)\]~2~ (0.005 mmol, 1 mol%) and (*R,R*)-Me-bipam (0.011 mmol, 2.2 mol%) under a nitrogen atmosphere. Toluene (3.0 mL) was added to the flask and the mixture was then stirred at room temperature for 30 min to prepare the catalyst. Isopropyl pyruvate (**2a**, 0.5 mmol), phenylboronic acid (**3a**, 0.75 mmol), KF (1.0 mmol), and H~2~O (0.3 mL) were then added to this catalyst solution. The reaction mixture was stirred at 80 °C for 16 h, at which time the crude reaction mixture extracted using ethyl acetate, washed with saturated NH~4~Cl and brine, and dried over MgSO~4~. Chromatography of the crude reaction mixture on silica gel gave *(S)-isopropyl 2-hydroxy-2-phenylpropanoate* (**5aa**) in 85% yield \[[@B44-molecules-16-05020],[@B45-molecules-16-05020],[@B46-molecules-16-05020]\]. \[α\]~D~^22^ = +40.00 (c 4.2, CHCl~3~), 93% ee \[HPLC conditions: Chiralcel OJ-H column, hexane/2-propanol = 98/2, flow = 1.0 mL/min, wavelength = 230 nm, t~major~ = 8.0 min and t~minor~ = 16.4 min\]; ^1^H-NMR (400 MHz, CDCl~3~) δ = 7.54-7.57 (m, 2H), 7.23-7.36 (m, 4H), 5.05 (sep, *J* = 6.4 Hz, 1H), 3.85 (s, 1H), 1.75 (s, 3H), 1.28 (d, *J* = 6.4 Hz, 3H), 1.17 (d, *J* = 6.0 Hz, 3H); ^13^C-NMR (100 MHz, CDCl~3~) δ = 175.3, 143.1, 128.3, 127.7, 125.2, 75.7, 70.4, 26.7, 21.8, 21.5; HRMS *m/z*; calcd. for C~12~H~16~O~3~Na: 231.09917; found 231.09919.

*Isopropyl* *2-hydroxy-2-(4-tolyl)propanoate* (**5ac**): \[α\]~D~^22^ = +34.40 (c 4.8, CHCl~3~), 89% ee \[HPLC conditions: Chiralcel OJ-H column, hexane/2-propanol = 98/2, flow = 1.0 mL/min, wavelength = 230 nm, t~major~ = 7.7 min and t~mainor~ = 14.8 min\]; ^1^H-NMR (400 MHz, CDCl~3~) δ = 7.43 (d, *J* = 8.2 Hz, 2H), 7.14 (d, *J* = 8.2 Hz, 2H), 5.04 (sep, *J* = 6.4 Hz, 1H), 3.78 (s, 1H), 2.33 (s, 3H), 1.73 (s, 3H), 1.27 (d, 3H, *J* = 6.5 Hz), 1.18 (d, *J* = 6.4 Hz, 3H); ^13^C-NMR (100 MHz, CDCl~3~) δ = 175.4, 140.2, 137.4, 129.0, 125.1, 75.5, 70.3, 26.7, 21.8, 21.5, 21.1; HRMS *m/z*; calcd. for C~13~H~18~O~3~Na: 245.11482; found 245.11494.

*Isopropyl* *2-hydroxy-2-(4-methoxyphenyl)propanoate* (**5ad**): \[α\]~D~^22^ = +37.85 (c 5.1, CHCl~3~), 91% ee \[HPLC conditions: Chiralcel OJ-H column, hexane/2-propanol = 98/2, flow = 1.0 mL/min, wavelength = 230 nm, t~major~ = 14.1 min and t~minor~ = 31.9 min\]; ^1^H-NMR (400 MHz, CDCl~3~) δ = 7.45 (d, *J* = 8.7 Hz, 2H), 6.85 (d, *J* = 8.7 Hz, 2H), 5.03 (sep, *J* = 6.4 Hz, 1H), 3.79 (s, 4H), 1.72 (s, 3H), 1.27 (d, *J* = 6.4 Hz, 3H), 1.16 (d, *J* = 6.0 Hz, 3H); ^13^C-NMR (100 MHz, CDCl~3~) δ = 175.5, 159.1, 135.2, 126.5, 113.6, 75.3, 70.3, 55.3, 26.7, 21.8, 21.5; HRMS *m/z*; calcd. for C~13~H~18~O~4~Na: 261.10973; found 261.10988.

*Isopropyl* *2-hydroxy-2-(4-fluorophenyl)propanoate* (**5af**): \[α\]~D~^22^ = +39.19 (c 5.0, CHCl~3~), 93% ee \[HPLC conditions: Chiralcel OJ-H column, hexane/2-propanol = 98/2, flow = 1.0 mL/min, wavelength = 230 nm, t~major~ = 7.2 min and t~minor~ = 10.0 min\]; ^1^H-NMR (400 MHz, CDCl~3~) δ = 7.50-7.55 (m, 2H), 6.98-7.03 (m, 2H), 5.04 (sep, *J* = 6.4 Hz, 1H), 3.87 (d, *J* = 0.9 Hz, 1H), 1.73 (s, 3H), 1.27 (d, *J* = 6.4 Hz, 3H), 1.16 (d, *J* = 6.0 Hz, 3H); ^13^C-NMR (100 MHz, CDCl~3~) δ = 175.1, 162.4 (d, *J* = 246 Hz), 138.8 (d, *J* = 2.86 Hz), 127.2 (d, *J* = 8.58 Hz), 115.1 (d, *J* = 21.93 Hz), 75.2, 70.5, 26.9, 21.7, 21.5; HRMS *m/z*; calcd. for C~12~H~15~O~3~FNa: 249.08974; found 249.08998.

*Isopropyl* *2-hydroxy-2-(4-trifluoromethylphenyl)propanoate* (**5ag**): \[α\]~D~^22^ = +30.04 (c 4.2, CHCl~3~), 92% ee \[HPLC conditions: Chiralcel OJ-H column, hexane/2-propanol = 98/2, flow = 1.0 mL/min, wavelength = 230 nm, t~major~ = 8.6 min and t~minor~ = 11.6 min\]; ^1^H-NMR (400 MHz, CDCl~3~) δ = 7.70 (d, *J* = 8.2 Hz, 2H), 7.59 (d, *J* = 8.2 Hz, 2H), 5.05 (sep, *J* = 6.4 Hz, 1H), 3.91 (s, 1H), 1.76 (s, 3H), 1.29 (d, *J* = 6.4 Hz, 3H), 1.18 (d, *J* = 6.4 Hz, 3H); ^13^C-NMR (100 MHz, CDCl~3~) δ = 174.6, 146.9, 130.0 (q, *J* = 32.4 Hz), 125.8, 125.5, 125.2 (q, *J* = 3.81 Hz), 122.8, 75.5, 70.9, 27.0, 21.7, 21.5; HRMS *m/z*; calcd. for C~13~H~15~O~3~F~3~Na: 299.08655; found 299.08701.

*Isopropyl* *2-hydroxy-2-(3-methoxyphenyl)propanoate* (**5ah**): \[α\]~D~^22^ = +26.54 (c 5.1, CHCl~3~), 92% ee \[HPLC conditions: Chiralcel OJ-H column, hexane/2-propanol = 98/2, flow = 1.0 mL/min, wavelength = 230 nm, t~major~ = 10.4 min and t~mainor~ = 20.5 min\]; ^1^H-NMR(400 MHz, CDCl~3~) δ = 7.23-7.27 (m, 1H), 7.11-7.13 (m, 2H), 6.80-6.83 (m, 1H), 5.05 (sep, *J* = 6.4 Hz, 1H), 3.80 (s, 4H), 1.73 (s, 3H), 1.28 (d, *J* = 6.4 Hz, 3H), 1.19 (d, *J* = 6.4 Hz, 3H); ^13^C-NMR (100 MHz, CDCl~3~) δ = 175.1, 159.6, 144.8, 129.3, 117.6, 113.2, 111.0, 75.7, 70.4, 55.3, 26.8, 21.7, 21.5; HRMS *m/z*; calcd. for C~13~H~18~O~4~Na: 261.10973; found 261.10993.

*Isopropyl* *2-hydroxy-2-(3-fluorophenyl)propanoate* (**5aj**): \[α\]~D~^22^ = +34.50 (c 4.0, CHCl~3~), 90% ee \[HPLC conditions: Chiralcel OJ-H column, hexane/2-propanol = 98/2, flow = 1.0 mL/min, wavelength = 230 nm, t~major~ = 5.9 min and t~minor~ = 7.7 min\]; ^1^H-NMR (400 MHz, CDCl~3~) δ = 7.25-7.34 (m, 3H), 6.94-6.99 (m, 1H), 5.05 (sep, *J* = 6.4 Hz, 1H), 3.86 (s, 1H), 1.73 (s, 3H), 1.29 (d, *J* = 6.4 Hz, 3H), 1.18 (d, *J* = 6.4 Hz, 3H); ^13^C-NMR (100 MHz, CDCl~3~) δ = 174.8, 162.8 (d, *J* = 245 Hz), 145.7 (d, *J* = 7.63 Hz), 129.8 (d, *J* = 8.58 Hz), 121.0, 114.6 (d, *J* = 20.98 Hz), 112.7 (d, *J* = 23.84 Hz), 75.3, 70.7, 26.8, 21.7, 21.5; HRMS *m/z*; calcd. for C~12~H~15~O~3~FNa: 249.08974; found 249.08997.

*Isopropyl* *2-hydroxy-2-(3-fluoro-4-methoxyphenyl)propanoate* (**5ak**): \[α\]~D~^22^ = +33.22 (c 5.2, CHCl~3~), 87% ee \[HPLC conditions: Chiralcel OJ-H column, hexane/2-propanol = 98/2, flow = 1.0 mL/min, wavelength = 230 nm, t~major~ = 13.1 min and t~minor~ = 21.2 min\]; ^1^H-NMR (400 MHz, CDCl~3~) δ = 7.23-7.30 (m, 2H), 6.90 (t, *J* = 8.7 Hz, 1H), 5.03 (sep, *J* = 6.4 Hz, 1H), 3.86 (s, 4H), 1.69 (s, 3H), 1.27 (d, *J* = 6.4 Hz, 3H), 1.17 (d, *J* = 6.4 Hz, 3H); ^13^C-NMR (100 MHz, CDCl~3~) δ = 175.0, 152.0 (d, *J* = 245 Hz), 147.1 (d, *J* = 11.44 Hz), 136.1 (d, *J* = 5.72 Hz), 121.1 (d, *J* = 2.86 Hz), 113.6 (d, *J* = 20 Hz), 112.9, 74.9, 70.6, 56.3, 26.8, 21.7, 21.5; HRMS *m/z*; calcd. for C~13~H~17~O~4~FNa: 279.10031; found 279.10049.

*Isopropyl* *2-hydroxy-2-phenylbutanoate* (**5ba**): \[α\]~D~^24^ = +38.66 (c 5.2, CHCl~3~), 95% ee \[HPLC conditions: Chiralcel OJ-H column, hexane/2-propanol = 98/2, flow = 1.0 mL/min, wavelength = 230 nm, t~major~ = 5.6 min and t~minor~ = 11.0 min\]; ^1^H-MR (400 MHz, CDCl~3~) δ = 7.58-7.61 (m, 2H), 7.24-7.36 (m, 3H), 5.06 (sep, *J* = 6.4 Hz, 1H), 3.81 (d, *J* = 0.92 Hz, 1H), 2.16-2.26 (m, 1H), 1.94-2.03 (m, 1H), 1.30 (d, *J* = 6.4 Hz, 3H), 1.19 (d, *J* = 6.4 Hz, 3H), 0.92 (t, *J* =7.3 Hz, 3H); ^13^C-NMR (100 MHz, CDCl~3~) δ = 175.0, 142.2, 128.2, 127.6, 125.6, 78.6, 70.4, 32.8, 21.8, 21.6, 8.1; HRMS *m/z*; calcd. for C~13~H~18~O~3~Na: 245.11482; found 245.11495.

*Isopropyl* *2-hydroxy-2-(4-tolyl)butanoate* (**5bc**): \[α\]~D~^25^ = +32.62 (c 4.8, CHCl~3~), 91% ee \[HPLC conditions: Chiralcel OJ-H column, hexane/2-propanol = 98/2, flow = 1.0 mL/min, wavelength = 230 nm, t~major~ = 6.0 min and t~minor~ = 10.2 min\]; ^1^H-NMR (400 MHz, CDCl~3~) δ = 7.47 (d, *J* = 8.2 Hz, 2H), 7.13 (d, *J* = 8.2 Hz, 3H), 5.04 (sep, *J* = 6.4 Hz, 1H), 3.76 (s, 1H), 2.32 (s, 3H), 2.15-2.24 (m, 1H), 1.91-2.00 (m, 1H), 1.29 (d, *J* = 6.4 Hz, 3H), 1.19 (d, *J* = 6.4 Hz, 3H), 0.91 (t, *J* =7.3 Hz, 3H); ^13^C-NMR (100 MHz, CDCl~3~) δ = 175.1, 139.3, 137.2, 128.9, 125.5, 78.5, 70.34, 32.8, 21.8, 21.6, 21.1, 8.1; HRMS *m/z*; calcd. for C~14~H~20~O~3~Na: 259.13047; found 259.13047.

*Isopropyl* *2-hydroxy-2-(4-fluorophenyl)butanoate* (**5bf**): \[α\]~D~^24^ = +39.18 (c 5.3, CHCl~3~), 93% ee \[HPLC conditions: Chiralcel OJ-H column, hexane/2-propanol = 98/2, flow = 1.0 mL/min, wavelength = 230 nm, t~major~ = 5.5 min and t~minor~ = 7.4 min\]; ^1^H-NMR (400 MHz, CDCl~3~) δ = 7.55-7.58 (m, 2H), 7.00 (t, *J* = 8.6 Hz, 2H), 5.05 (sep, *J* = 6.4 Hz, 1H), 3.84 (s, 1H), 2.13-2.22 (m, 1H), 1.90-1.99 (m, 1H), 1.30 (d, *J* = 6.4 Hz, 3H), 1.17 (d, *J* = 6.4 Hz, 3H), 0.90 (t, *J* = 7.3 Hz, 3H); ^13^C-NMR (100 MHz, CDCl~3~) δ = 174.80, 162.32 (d, *J* = 245 Hz), 137.8 (d, *J* = 2.86 Hz), 127.5 (d, *J* = 8.58 Hz), 114.9 (d, *J* = 20.98 Hz), 78.2, 70.6, 32.9, 21.8, 21.6, 8.0; HRMS *m/z*; calcd. for C~13~H~17~O~3~FNa: 263.10539; found 263.10540.

*Isopropyl* *2-hydroxy-2-(3-methoxyphenyl)butanoate* (**5bh**): \[α\]~D~^25^ = +26.66 (c 3.1, CHCl~3~), 91% ee \[HPLC conditions: Chiralcel OJ-H column, hexane/2-propanol = 98/2, flow = 1.0 mL/min, wavelength = 230 nm, t~major~ = 8.0 min and t~minor~ = 12.7 min\]; ^1^H-NMR (400 MHz, CDCl~3~) δ = 7.16-7.26 (m, 3H), 6.79-6.82 (m, 1H), 5.05 (sep, *J* = 6.4 Hz, 1H), 3.79 (s, 4H), 2.14-2.23 (m, 1H), 1.92-2.01 (m, 1H), 1.30 (d, *J* = 6.4 Hz, 3H), 1.20 (d, *J* = 6.4 Hz, 3H), 0.91 (t, *J* = 7.3 Hz, 3H); ^13^C-NMR (100 MHz, CDCl~3~) δ = 174.8, 159.5, 143.9, 129.1, 118.0, 113.1, 111.3, 78.6, 70.5, 55.3, 32.9, 21.8, 21.61, 8.1; HRMS *m/z*; calcd. for C~12~H~20~O~4~Na: 275.12593; found 275.12485.

*Isopropyl* *2-hydroxy-3-methyl-2-phenylbutanoate* (**5ca**): \[α\]~D~^22^ = +5.95 (c 3.4, CHCl~3~), 94% ee \[HPLC conditions: Chiralcel OJ-H column, hexane/2-propanol = 98/2, flow = 1.0 mL/min, wavelength = 230 nm, t~major~ = 4.1 min and t~minor~ = 5.2 min\]; ^1^H-NMR (400 MHz, CDCl~3~) δ = 7.62-7.65 (m, 2H), 7.23-7.34 (m, 3H), 5.03 (sep, *J* = 6.6 Hz, 1H), 3.71 (s, 1H), 2.59 (sep, *J* = 6.9 Hz, 1H), 1.32 (d, *J* = 6.0 Hz, 3H), 1.17 (d, *J* = 6.0 Hz, 3H), 0.98 (d, *J* = 6.8 Hz, 3H), 0.68 (d, *J* = 6.9 Hz, 3H); ^13^C-NMR (100 MHz, CDCl~3~) δ = 175.3, 141.5, 128.0, 127.4, 126.0, 80.7, 70.5, 35.8, 21.8, 21.6, 17.1, 15.9; HRMS *m/z*; calcd. for C~14~H~20~O~3~Na: 259.13047; found 259.13042.

*Isopropyl* *2-hydroxy-3-methyl-2-(4-methoxyphenyl)butanoate* (**5cd**): \[α\]~D~^22^ = +36.53 (c 3.5, CHCl~3~), 90% ee \[HPLC conditions: Chiralcel OJ-H column, hexane/2-propanol = 98/2, flow = 1.0 mL/min, wavelength = 230nm, t~major~ = 5.9 min and t~minor~ = 7.1 min\]; ^1^H-NMR (400 MHz, CDCl~3~) δ = 7.54 (d, *J* = 9.1 Hz, 2H), 6.85 (d, *J* = 9.1 Hz, 2H), 5.02 (sep, *J* = 6.4 Hz, 1H), 3.79 (s, 3H), 3.68 (s, 1H), 2.54 (sep,*J* = 6.9 Hz, 1H), 1.31 (d, *J* = 6.4 Hz, 3H), 1.17 (d, *J* = 6.4 Hz, 3H), 0.96 (d, *J* = 6.4 Hz, 3H), 0.68 (d, *J* = 7.3 Hz, 3H); ^13^C-NMR (100 MHz, CDCl~3~) δ = 175.5, 158.9, 133.6, 127.2, 113.3, 80.4, 70.4, 55.3, 35.7, 21.8, 21.6, 17.0, 15.9; HRMS *m/z*; calcd. for C~15~H~22~O~4~Na: 289.14103; found 289.14093.

*Isopropyl* *2-hydroxy-2-phenyl-2-(4-tolyl)acetate* (**5dc**): \[α\]~D~^24^ = −4.14 (c 5.2, CHCl~3~), 92% ee \[HPLC conditions: Chiralcel OJ-H column, hexane/2-propanol = 98/2, flow = 1.0 mL/min, wavelength = 230 nm, t~major~ = 18.4 min and t~minor~ = 20.8 min\]; ^1^H-NMR (400 MHz, CDCl~3~) δ = 7.42-7.44 (m, 2H), 7.29-7.34 (m, 5H), 7.13 (d, *J* = 8.2 Hz, 2H), 5.14 (sep, *J* = 6.4 Hz, 1H), 4.26 (s, 1H), 2.34 (s, 3H), 1.24 (t, *J* = 6.4 Hz, 6H); ^13^C-NMR (100 MHz, CDCl~3~) δ = 174.2, 142.3, 139.3, 137.7, 128.8, 128.0, 127.9, 127.5, 127.4, 80.7, 71.2, 21.6, 21.2; HRMS *m/z*; calcd. for C~18~H~20~O~3~Na: 307.13047; found 307.13070.

*Isopropyl 2\--2-hydroxy-2-(4-methoxyphenyl)-2-phenylacetate* (**5dd**): \[α\]~D~^25^ = +2.10 (c 4.0, CHCl~3~), 86% ee \[HPLC conditions: Chiralcel AS-H column, hexane/2-propanol = 9/1, flow = 1.0 mL/min, wavelength = 230 nm, t~major~ = 20.2 min and t~minor~ = 22.8 min\]; ^1^H-NMR (400 MHz, CDCl~3~) δ = 7.43-7.45 (m, 2H), 7.30-7.36 (m, 5H), 6.87-6.85 (d, *J* = 8.7 Hz, 2H), 5.15 (sep, *J* = 6.4 Hz, 1H), 4.28 (d, *J* = 2.3 Hz, 1H), 3.80 (s, 3H), 1.24 (dd, *J* = 6.4, 6.4Hz, 6H); ^13^C-NMR (100 MHz, CDCl~3~) δ = 174.2, 159.3, 142.4, 134.4, 128.8, 128.1, 128.0, 127.5, 113.4, 80.5, 71.2, 55.4, 21.6, 21.6; HRMS *m/z*; calcd. for C~18~H~20~O~4~Na: 323.12593; found 323.12614.

*Isopropyl 2-(4-chlorophenyl)-2-hydroxy-2-phenylacetate* (**5de**) \[[@B47-molecules-16-05020]\]: \[α\]~D~^20^ = +17.87 (c 4.9, CHCl~3~), 91% ee \[HPLC conditions: Chiralcel AD-H column, hexane/2-propanol = 9/1, flow = 1.0 mL/min, wavelength = 230 nm, t~minor~ = 18.9 min and t~major~ = 20.0 min\]; ^1^H-NMR (400 MHz, CDCl~3~) δ = 7.28-7.40 (m, 9H), 5.15 (sep, *J* = 6.4 Hz, 1H), 4.30 (s, 1H), 1.24 (dd, *J* = 6.4, 6.0 Hz, 6H); ^13^C-NMR (100 MHz, CDCl~3~) δ = 173.6, 142.0, 140.6, 134.0, 129.0, 128.3, 128.2, 128.2, 127.3, 80.4, 71.5, 21.6; HRMS m/z; calcd. for C~17~H~17~O~3~ClNa: 327.07584; found 327.07589.

*Isopropyl* *2-(4-fluorophenyl)-2-hydroxy-2-phenylacetate* (**5df**): \[α\]~D~^24^ = +15.96 (c 4.9, CHCl~3~), 94% ee \[HPLC conditions: Chiralcel OJ-H column, hexane/2-propanol = 98/2, flow = 1.0 mL/min, wavelength = 230 nm, t~major~ = 10.3 min and t~minor~ = 11.4 min\]; ^1^H-NMR (400 MHz, CDCl~3~) δ = 7.30-7.44 (m, 7H), 7.00 (t, *J* = 8.7 Hz, 2H), 5.15 (sep, *J* = 6.4 Hz, 1H), 4.31 (s, 1H), 1.24 (dd, *J* = 6.4, 6.4 Hz, 6H); ^13^C-NMR (100 MHz, CDCl~3~) δ = 173.9, 162.5 (d, *J* = 247.0 Hz), 142.1, 137.9 (d, *J* = 2.86 Hz), 129.40 (d, *J* = 8.58 Hz), 128.23, 128.17, 127.3, 114.9 (d, *J* = 20.98 Hz), 80.4, 71.4, 21.6; HRMS *m/z*; calcd. for C~17~H~17~O~3~FNa: 311.10539; found 311.10545.

*Isopropyl* *2-hydroxy-2-(3-methoxyphenyl)-2-phenylacetate* (**5dh**): \[α\]~D~^25^ = −3.95 (c 2.7, CHCl~3~), 92% ee \[HPLC conditions: Chiralcel AD-H column, hexane/2-propanol = 9/1, flow = 0.85 mL/min, wavelength = 230 nm, t~major~ = 14.5 min and t~minor~ = 15.3 min\]; ^1^H-NMR (400 MHz, CDCl~3~) δ = 7.41-7.44 (m, 2H), 7.22-7.35 (m, 4H), 7.01-7.03 (m, 2H), 6.84-7.03 (m, 1H), 5.15 (sep, *J* = 6.4 Hz, 1H), 4.32 (s, 1H), 3.76 (s, 3H), 1.25 (t, *J* = 6.5 Hz, 6H); ^13^C-NMR (100 MHz, CDCl~3~) δ = 173.9, 159.4, 143.6, 142.0, 129.1, 128.1, 128.0, 127.5, 120.0, 113.6, 113.2, 80.8, 71.3, 55.3, 21.6, 21.6; HRMS *m/z*; calcd. for C~18~H~20~O~4~Na: 323.12593; found 323.12638.

*Isopropyl 2-(3-chlorophenyl)-2-(4-fluorophenyl)-2-hydroxyacetate* (**5ei**): \[α\]~D~^22^ = +1.23 (c 5.3, CHCl~3~), 90% ee \[HPLC conditions: Chiralcel OJ-H column, hexane/2-propanol = 98/2, flow = 1.0 mL/min, wavelength = 230 nm, t~major~ = 10.9 min and t~minor~ = 12.2 min\]; ^1^H-NMR (400 MHz, CDCl~3~) δ = 7.25-7.45 (m, 6H), 7.02 (m, 2H), 5.16 (sep, *J* = 6.4 Hz, 1H), 1.25 (d, *J* = 6.4 Hz, 6H); ^13^C-NMR (100 MHz, CDCl~3~) δ = 173.3, 162.6 (d,*J* = 247 Hz), 143.9, 137.4 (d, *J* = 2.86 Hz), 134.2, 129.4, 129.2 (d, *J* = 8.58 Hz), 128.4, 127.6, 125.7, 115.1 (d, *J* = 20.98 Hz), 79.9, 71.8, 21.6; HRMS *m/z*; calcd. for C~17~H~16~O~3~ClFNa: 345.06642; found 345.06639.

4. Conclusions
==============

In summary, we have developed a catalytic asymmetric arylation of aliphatic aldehydes and α-ketoesters with arylboronic acids by RuCl~2~(p-cymene)/Me-BIPAM catalyst. With this catalyst system, a broad range of enantiopure alkyl(aryl)methanols and α-hydroxy-esters were easily prepared. Studies on further applications of Me-BIPAM to other C-C bond-forming reactions are in progress in our group.
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*Sample Availability:* Me-BIPAM and *N*-Me-BIPAM are available from the authors.
